# RYTHM, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/RYTHM, Inc.). ## Overview RYTHM, Inc. is a U.S.-based consumer products company focused on hemp-derived THC beverages, edibles, and other branded cannabinoid products. Through its subsidiaries, it also licenses intellectual property and brand rights to third parties, with a portfolio that includes RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, Good Green, and Señorita. ## Products & services • Hemp-derived THC beverages • Hemp-derived edibles and gummies • Licensed consumer packaged goods brands • Brand and intellectual property licensing • Online and direct-to-retail product sales - **Hemp-derived THC beverages** (45%) — Ready-to-drink hemp THC beverages sold under the Señorita and RYTHM brands. - **Hemp-derived edibles** (35%) — Edible cannabinoid products including gummies and related formats under brands such as incredibles and Beboe. - **Licensed consumer brands** (20%) — Brand rights licensed to third parties for manufacturing and distribution in exchange for fees. - Hemp-derived THC beverages - Hemp-derived edibles and gummies - Licensed consumer packaged goods brands - Brand and intellectual property licensing - Online and direct-to-retail product sales ## Customers RYTHM sells to consumers seeking hemp-derived THC alternatives to alcohol and traditional cannabis products, especially in beverage and edible formats. It also serves retail partners and distributors that carry its branded products, as well as a related-party licensee that uses its intellectual property in state-licensed cannabis operations. - **Adult hemp beverage consumers** (primary) — Buy Señorita and similar THC beverages as alcohol alternatives for social occasions and relaxation. - **Edible cannabinoid consumers** (primary) — Purchase gummies and other ingestible products for convenience, discretion, and brand preference. - **Retail and distribution partners** (secondary) — Stock and distribute branded products because they want differentiated hemp THC offerings. - **Licensing counterparties** (secondary) — Use the company’s brands and intellectual property in exchange for sales-based fees. - Adult consumers buying hemp-derived THC beverages and edibles - Retail chains and beverage retailers carrying Señorita - Direct-to-retail partners distributing branded hemp products - Online shoppers purchasing RYTHM and incredibles products - Licensed cannabis operators using RYTHM intellectual property ## Geography RYTHM is headquartered in the United States and sells primarily in U.S. states where hemp-derived THC products are permitted. The company also sells Señorita in Canada and has described expansion into additional retail and on-premises channels, making regulatory access a key part of its geographic footprint. - United States is the core market for hemp-derived THC products - Sales are concentrated in states where hemp THC is permitted - Señorita is sold in eleven U.S. states and Canada - Canada is an international market for select beverage products - Geographic access depends on state and federal hemp rules ## Strategy RYTHM’s strategy centers on repositioning the business around hemp-derived THC beverages and branded consumer products while monetizing its intellectual property through licensing. It is also building distribution through retail partnerships, online channels, and selective geographic expansion where hemp products are permitted. - **Build a hemp-derived beverage platform** (short-term) — Beverages are the most visible consumer-facing category and can drive repeat purchases and brand recognition. - **Scale branded consumer packaged goods** (medium-term) — A broader portfolio improves shelf presence and reduces reliance on any single product format. - **Monetize intellectual property through licensing** (medium-term) — Licensing can extend brand reach without requiring full manufacturing and distribution ownership. - Expand hemp-derived THC beverage distribution - Grow branded edible and beverage portfolios - Use licensing to monetize brand intellectual property - Broaden retail and direct-to-retail partnerships - Pursue selective expansion in permitted markets ## Risks RYTHM is exposed to regulatory risk because hemp-derived THC products depend on federal, state, and local rules that can change or tighten. The business also faces concentration risk in a narrow product set and limited geographies, plus execution risk around product acceptance, retailer adoption, licensing relationships, and access to financing. - **Federal or state restrictions on hemp-derived THC products** [high] — The company’s core products depend on the legal status of hemp THC and related enforcement interpretations. - **Customer licensing and regulatory compliance risk** [medium] — Some customers must maintain licenses to operate, and loss of those licenses can reduce sales and licensing revenue. - **Product acceptance and competition** [medium] — Branded hemp products compete with alcohol, cannabis, and other consumer packaged goods offerings. - **Geographic concentration** [high] — Sales are limited to jurisdictions that permit hemp-derived THC products, increasing regulatory and market concentration. - **Financing and liquidity access** [high] — The business may need external capital to support working capital and growth, and funding terms may be unfavorable. - Hemp THC rules could change and restrict product sales - Business is concentrated in a narrow product and geography set - Retail and licensing partners may not maintain demand or access - New products may fail to gain market acceptance - Banking and financing access can be difficult in hemp/cannabis ## Accounting Revenue recognition is important because the company records both product sales and sales-based licensing fees, which can differ in timing and measurement. Investors should also watch fair value accounting for warrants and derivative liabilities, as well as goodwill impairment testing and acquisition accounting tied to brand and asset purchases. - **Revenue recognition for product sales and licensing fees** — Affects reported revenue mix and quarter-to-quarter comparability - **Fair value of warrant liabilities and derivatives** — Can create large non-cash swings in earnings - **Goodwill impairment** — Potential for material write-downs if expectations weaken - **Business combinations and asset acquisitions** — Influences intangible assets, amortization, and future impairment risk - Product revenue is recognized under ASC 606 when performance obligations are met - Licensing revenue depends on sales-based fee arrangements - Fair value changes in warrants can create non-cash earnings volatility - Goodwill is tested for impairment and can be written down - Business combinations and asset acquisitions affect asset values and future amortization --- *Last updated: 2026-04-29T04:52:40.858590+00:00*